Peptide Care in Michigan: Match the Credential to the Clinician

The Michigan LARA: Medicine page provides the state’s medicine-profession resources and access to professional verification. The FSMB: Contact a state medical board directory separately identifies Michigan’s medicine and osteopathic boards. Ask for the clinician’s professional designation, full name, and license number so you know which record you need.

An unfamiliar result should prompt a careful identity check, not an immediate judgment. Confirm that the number belongs to the treating individual and review the current status. Do not treat a business registration or a photograph of a clinic certificate as a substitute for the professional’s credential.

A clinician’s license concerns professional authority. A pharmacy’s credential concerns the dispensing entity. A laboratory report concerns the tested material and the methods used. None can automatically stand in for the other two, and together they still do not establish that a proposed treatment is suitable for a particular patient.

Ask the service to identify the medical practice and dispensing pharmacy in writing. Then ask the clinician to explain the health problem being addressed and the evidence for the exact product. A broad claim about peptide benefits is not enough to understand a recommendation for an individual condition.

Tell the practice where you will physically be during the appointment. HHS: Licensing across state lines describes why state-specific authority matters in cross-state telehealth. If a follow-up occurs outside Michigan, share that change before the encounter rather than assuming the account’s home address controls the arrangement.

Ask what happens if a remote assessment is insufficient. Identify who arranges an examination, receives tests, and communicates with your usual clinician. These steps should be understandable before you need them, especially if multiple practices are involved in treating the same concern.

If a compounded drug is proposed, FDA: Compounding questions and answers explains that it is not FDA-approved. Discuss why an approved product would not meet the medical need and what evidence and uncertainties apply to the proposed formulation. A research-only label does not establish a patient treatment pathway.

Compare the evaluation and follow-up fees with the medication and testing costs. Ask how you stop recurring payments, obtain your records, and transfer care if the arrangement ends. Keep the assessment and pharmacy details together. A usable record helps a new clinician understand the plan without trying to reconstruct it from a brand name or a social-media advertisement.